Bard C R Inc /nj/ (BCR) Files Form 4 Insider Selling : John P Groetelaars Sells 1,162 Shares

Bard C R Inc /nj/ (BCR): John P Groetelaars , Group President of Bard C R Inc /nj/ sold 1,162 shares on May 17, 2016. The Insider selling transaction was reported by the company on May 18, 2016 to the Securities and Exchange Commission. The shares were sold at $219.88 per share for a total value of $255,505.20 , the company said in a SEC Form 4 Filing.

Other Insider transactions have been reported by the company according to SEC Form 4, on May 16, 2016, Tommy G Thompson (director) sold 500 shares at $219.52 per share price.On May 9, 2016, Tony L White (director) sold 1,200 shares at $216.19 per share price.Also, On May 2, 2016, Jim C Beasley (Group President) sold 4,709 shares at $215.00 per share price.On Apr 29, 2016, Sharon M Luboff (Group Vice President) sold 10,000 shares at $210.00 per share price.

C R Bard Inc: On Thursday, May 19, 2016 heightened volatility was witnessed in C R Bard Inc which led to swings in the share price. The shares opened for trading at $217.16 and hit $218.96 on the upside , eventually ending the session at $218.58, with a gain of 0.20% or 0.44 points. The heightened volatility saw the trading volume jump to 3,43,009 shares. The 52-week high of the share price is $223.02 and the company has a market cap of $16,026 M . The 52-week low of the share price is at $167.36.

C R Bard Inc Money Flow Index Chart

Company has been under the radar of several Street Analysts.C R Bard Inc is Reiterated by Barclays to Equal Weight and the brokerage firm has raised the Price Target to $ 212 from a previous price target of $195 .The Rating was issued on Apr 28, 2016.C R Bard Inc is Initiated by Nomura to Neutral. The Rating was issued on Mar 17, 2016.

C. R. Bard Inc. (Bard) and its subsidiaries are engaged in the design manufacture packaging distribution and sale of medical surgical diagnostic and patient care devices. . The Company reports its sales in four major product group categories: vascular urology oncology and surgical specialty. The Company also has a product group of other products. The Company’s vascular products cover a range of minimally invasive devices for the treatment of peripheral vascular disease and heart arrhythmias. Its urology products include basic urology drainage products fecal and urinary continence products urological specialty products and Targeted Temperature Management products. Its oncology products cover a range of devices used in the treatment and management of various cancers and other diseases and disorders. Its surgical specialty products include implanted patches and fixation devices for hernia and other soft tissue repairs in addition to hemostats and surgical sealants.

Leave a Reply

C R Bard Inc - Is it time to Sell?

Top Brokerage Firms are advising their investors on C R Bard Inc. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.